T1	Chemical	10 19	Veliparib
T2	Chemical	24 38	PARP inhibitor
T3	Chemical	72 113	in combination with oral cyclophosphamide
T4	Disease	131 159	BRCA -mutant solid tumors in
R1	influences	Arg1:T1	Arg2:T3
R2	treats	Arg1:T1	Arg2:T4
R3	influences	Arg1:T2	Arg2:T1
R4	influences	Arg1:T2	Arg2:T3
R5	treats	Arg1:T2	Arg2:T4
R6	influences	Arg1:T3	Arg2:T1
R7	influences	Arg1:T3	Arg2:T2
R8	treats	Arg1:T3	Arg2:T4
R9	isAssociatedWith	Arg1:T4	Arg2:T1
